Abstract
Cancer remains as the subsequent cause of death in the contemporary society trailing after heart disease. Abrus precatorius, a vine of the Fabaceae family, has proven to be immensely beneficial in cancer management. Its seeds, leaves androots are rich source of phytochemicals such as terpenoids, alkaloids, lectin proteins, flavonoids, tannins and phenolic compounds. These metabolites possess a plethora of properties such as anti-cancer, anti-angiogenic, antioxidant, anti-inflammatory etc. This review takes a comprehensive and critical look at the evidence on Abrus-derived metabolites in cancer therapy. It reviews the results of preclinical (in-vitro and in-vivo) investigations on the therapeutic potential of A. precatorius metabolites targeting a wide range of malignancies including those of the gastrointestinal tract, breast, gynaecological related, urogenital cancer etc. The review also explores the existing limitations and concerns in this field, as well as the post-analysis recommendation to guide future research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of microbiology, biotechnology and food sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
